37.66
Atricure Inc stock is traded at $37.66, with a volume of 525.42K.
It is up +5.40% in the last 24 hours and up +28.23% over the past month.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
See More
Previous Close:
$35.73
Open:
$36.35
24h Volume:
525.42K
Relative Volume:
1.01
Market Cap:
$1.87B
Revenue:
$499.95M
Net Income/Loss:
$-36.36M
P/E Ratio:
-48.91
EPS:
-0.77
Net Cash Flow:
$24.22M
1W Performance:
+6.23%
1M Performance:
+28.23%
6M Performance:
-1.90%
1Y Performance:
+54.66%
Atricure Inc Stock (ATRC) Company Profile
Name
Atricure Inc
Sector
Industry
Phone
513-755-4100
Address
7555 INNOVATION WAY, MASON, OH
Compare ATRC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ATRC
Atricure Inc
|
37.66 | 1.77B | 499.95M | -36.36M | 24.22M | -0.77 |
![]()
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
![]()
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-17-24 | Resumed | JP Morgan | Overweight |
Apr-23-24 | Upgrade | Oppenheimer | Perform → Outperform |
Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
Sep-29-23 | Initiated | UBS | Buy |
Aug-05-21 | Downgrade | Oppenheimer | Outperform → Perform |
Dec-18-20 | Reiterated | Needham | Buy |
Nov-06-20 | Reiterated | Needham | Buy |
Apr-07-20 | Initiated | Oppenheimer | Outperform |
Feb-06-20 | Initiated | BTIG Research | Buy |
Jan-24-20 | Reiterated | Needham | Buy |
Aug-13-19 | Downgrade | Northland Capital | Outperform → Market Perform |
Apr-12-19 | Initiated | JP Morgan | Overweight |
Oct-04-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Stifel | Buy |
Jun-18-18 | Reiterated | Needham | Buy |
Apr-27-18 | Reiterated | Needham | Buy |
Jan-16-18 | Reiterated | Needham | Buy |
Nov-02-17 | Reiterated | Needham | Buy |
Jul-28-17 | Reiterated | Needham | Buy |
May-30-17 | Resumed | Piper Jaffray | Overweight |
Jun-30-16 | Resumed | JMP Securities | Mkt Outperform |
Oct-28-15 | Reiterated | Needham | Buy |
Oct-06-15 | Reiterated | Canaccord Genuity | Buy |
Oct-06-15 | Reiterated | Needham | Buy |
View All
Atricure Inc Stock (ATRC) Latest News
Leading Afib Treatment Innovator AtriCure to Present at Wells Fargo Healthcare Conference September 2025 - Stock Titan
AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 40% Upside Potential Driven by Strong Analyst Support - DirectorsTalk Interviews
Will AtriCure Inc. continue its uptrend2025 Top Gainers & High Conviction Buy Zone Alerts - Newser
Volume Profile Shows Strong Base for AtriCure Inc.Take Profit & Community Verified Trade Signals - sundaytimes.kr
Is AtriCure Inc. stock a good hedge against inflationPrice Action & AI Forecasted Entry/Exit Points - Newser
Can a trend reversal in AtriCure Inc. lead to recovery2025 Market Sentiment & Expert Verified Movement Alerts - Newser
Using Bollinger Bands to evaluate AtriCure Inc.2025 Top Gainers & Expert Curated Trade Setups - Newser
Trend Dashboard Flags AtriCure Inc. As Potential Swing TradeWeekly Investment Report & Free Weekly Watchlist of Top Performers - newsyoung.net
How AtriCure Inc. stock performs during market volatilityWeekly Market Summary & Expert Approved Momentum Ideas - Newser
Is AtriCure Inc. a candidate for recovery playBond Market & Short-Term Trading Opportunity Alerts - Newser
Candlestick signals on AtriCure Inc. stock today2025 Macro Impact & Technical Confirmation Alerts - Newser
What technical models suggest about AtriCure Inc.’s comebackJuly 2025 Gainers & Weekly High Conviction Trade Ideas - Newser
Is AtriCure Inc. meeting your algorithmic filter criteriaInflation Watch & Real-Time Price Movement Reports - Newser
Can swing trading help recover from AtriCure Inc. lossesM&A Rumor & Daily Stock Trend Reports - Newser
AtriCure Inc. stock prediction for this week2025 Market Sentiment & Free Community Supported Trade Ideas - Newser
Why AtriCure Inc. stock attracts strong analyst attentionShort Setup & Fast Gain Stock Trading Tips - Newser
Should I trade or invest in AtriCure Inc.July 2025 Pullbacks & Free Community Supported Trade Ideas - newsyoung.net
What machine learning models say about AtriCure Inc.Index Update & AI Enhanced Trading Alerts - Newser
AtriCure at Canaccord Conference: Innovation Fuels Growth By Investing.com - Investing.com Canada
How Investors Are Reacting To AtriCure (ATRC) Raising 2025 Revenue Outlook After Strong Q2 Results - simplywall.st
Will Breakout in AtriCure Inc. Sustain Through Next WeekWeekly Watchlist of High Movers Released - beatles.ru
AtriCure, Inc. : Positioned for Growth in Surgical Afib Solutions - MarketScreener
What makes AtriCure Inc. stock price move sharplySwing Gain Strategy with Entry Forecast - Newser
Visual analytics tools that track AtriCure Inc. performanceEarnings Report Summary with Market Impact - Newser
Atricure Director Makes a Significant Stock Sale! - TipRanks
AtriCure (ATRC) Q2 2025 Earnings Call Transcript - Mitrade
Atricure’s CSO Makes a Strategic Stock Move! - TipRanks
AtriCure CSO Doraiswamy sells $91k in stock By Investing.com - Investing.com South Africa
AtriCure CSO Doraiswamy sells $91k in stock - Investing.com
Momentum Indicator Shows Bearish Divergence in AtriCure Inc.Beginner Friendly Stock Selection Guide Updated - beatles.ru
A Quick Look at Today's Ratings for AtriCure(ATRC.US), With a Forecast Between $42 to $60 - 富途牛牛
Eighteen-Month LeAAPS Trial Enrollment Completed - Medical Product Outsourcing
Building trade automation scripts for AtriCure Inc.Momentum-Based Prediction for Quick Returns - Newser
Wall Street Zen Upgrades AtriCure (NASDAQ:ATRC) to Buy - Defense World
What drives AtriCure Inc. stock priceMaximize gains with professional stock picks - Jammu Links News
AtriCure Q2 Adjusted Loss Narrows, Revenue Rises - 富途牛牛
When is AtriCure Inc. stock expected to show significant growthAccelerated investment success - Jammu Links News
What catalysts could drive AtriCure Inc. stock higher in 2025Powerful profit generation - Jammu Links News
How many analysts rate AtriCure Inc. as a “Buy”Capitalize on emerging market sectors - Jammu Links News
AtriCure Inc. Stock Analysis and ForecastTriple-digit wealth increases - Jammu Links News
How strong is AtriCure Inc. company’s balance sheetAchieve consistent double-digit growth - Jammu Links News
What are the latest earnings results for AtriCure Inc.Consistent triple returns - Jammu Links News
Is AtriCure Inc. a good long term investmentBuild wealth with proven stock investing tactics - Jammu Links News
What is the dividend policy of AtriCure Inc. stockUnlock powerful trading tools for investors - Jammu Links News
What are AtriCure Inc. company’s key revenue driversCapitalize on emerging market sectors - Jammu Links News
How volatile is AtriCure Inc. stock compared to the marketSuperior return velocity - Jammu Links News
Atricure Inc Stock (ATRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Atricure Inc Stock (ATRC) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
GROVES REGINA E | Director |
Aug 06 '25 |
Sale |
36.82 |
2,452 |
90,283 |
33,715 |
Doraiswamy Vinayak | Chief Scientific Officer |
Aug 05 '25 |
Sale |
36.58 |
2,500 |
91,450 |
71,872 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):